Billionaire Profile
Felix Baker
Global Rank
#1264

Image: Unsplash Contributor | Unsplash License | via Unsplash

Felix Baker

CEO, Biotech investing
UNITED STATES
Real-Time Net Worth
$3.393B
Estimated based on Biotech investing stock value as of April 20, 2026
0% (24h)
Age
56
Source
Biotech investing
Industry
Finance & Investments
Citizenship
UNITED STATES

Biography

Felix Baker is a prominent figure in the biotechnology investment sector, co-founding Baker Bros. Advisors in 2000. His career began in 1994 with a biotechnology investment partnership with the Tisch Family. Baker's expertise in biotech investing has led to a current estimated net worth of $3.4 billion. He is a director for several biotechnology companies and a Stanford University alumnus with a Ph.D. in immunology.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life and Education

Felix Baker was born in March 1969. He graduated from Stanford University with a B.S. in Biology and a Ph.D. in Immunology, having also completed two years of medical school. His academic background provided a solid foundation for his career in biotechnology.

Rise to Success

Baker's career in finance began in 1994, with a biotechnology investment partnership with the Tisch family. In 2000, he co-founded Baker Bros. Advisors with his brother, Julian Baker. The firm is a New York-based hedge fund specializing in biotechnology investments. The firm's success is reflected in its management of over $18 billion in assets as of March 2025. Baker's firm has been noted for its strong returns, with an estimated $8 billion gain from an early investment in Seagen.

Key Business Strategies

Baker Bros. Advisors focuses on long-term value creation within the biotech sector through a research-driven strategy, often backing early-stage companies. The firm's approach includes deep scientific due diligence and holding positions through clinical trial phases.

Philanthropy

Felix Baker serves on the advisory council that oversees the interdisciplinary biosciences institutes at Stanford, including Bio-X, the Neurosciences Institute, and ChEM-H. The firm has a reputation for a personalized approach to wealth management and for delivering solutions tailored to client needs.

Career Milestones

1994

Biotechnology Investment Partnership

Began a biotechnology investment partnership with the Tisch family.

2000

Co-founded Baker Bros. Advisors

Co-founded Baker Bros. Advisors, a hedge fund specializing in biotechnology investments, with his brother Julian Baker.

Philanthropy & Social Impact

Education

Stanford University Support

Unknown

Serves on advisory councils for Stanford's biosciences institutes.